409 related articles for article (PubMed ID: 18458226)
1. Protective effects of NSAIDs on the development of Alzheimer disease.
Vlad SC; Miller DR; Kowall NW; Felson DT
Neurology; 2008 May; 70(19):1672-7. PubMed ID: 18458226
[TBL] [Abstract][Full Text] [Related]
2. No advantage of A beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies.
Szekely CA; Green RC; Breitner JC; Østbye T; Beiser AS; Corrada MM; Dodge HH; Ganguli M; Kawas CH; Kuller LH; Psaty BM; Resnick SM; Wolf PA; Zonderman AB; Welsh-Bohmer KA; Zandi PP
Neurology; 2008 Jun; 70(24):2291-8. PubMed ID: 18509093
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of action of non-steroidal anti-inflammatory drugs for the prevention of Alzheimer's disease.
Cole GM; Frautschy SA
CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):140-8. PubMed ID: 20205646
[TBL] [Abstract][Full Text] [Related]
4. From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: the role of NSAIDs and cyclooxygenase in beta-amyloidosis and clinical dementia.
Pasinetti GM
J Alzheimers Dis; 2002 Oct; 4(5):435-45. PubMed ID: 12446975
[TBL] [Abstract][Full Text] [Related]
5. The anti-inflammatory and cholinesterase inhibitor bifunctional compound IBU-PO protects from beta-amyloid neurotoxicity by acting on Wnt signaling components.
Farías GG; Godoy JA; Vázquez MC; Adani R; Meshulam H; Avila J; Amitai G; Inestrosa NC
Neurobiol Dis; 2005 Feb; 18(1):176-83. PubMed ID: 15649708
[TBL] [Abstract][Full Text] [Related]
6. Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease.
Wahner AD; Bronstein JM; Bordelon YM; Ritz B
Neurology; 2007 Nov; 69(19):1836-42. PubMed ID: 17984451
[TBL] [Abstract][Full Text] [Related]
7. Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort.
Breitner JC; Haneuse SJ; Walker R; Dublin S; Crane PK; Gray SL; Larson EB
Neurology; 2009 Jun; 72(22):1899-905. PubMed ID: 19386997
[TBL] [Abstract][Full Text] [Related]
8. A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity.
Weggen S; Eriksen JL; Das P; Sagi SA; Wang R; Pietrzik CU; Findlay KA; Smith TE; Murphy MP; Bulter T; Kang DE; Marquez-Sterling N; Golde TE; Koo EH
Nature; 2001 Nov; 414(6860):212-6. PubMed ID: 11700559
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease.
Yan Q; Zhang J; Liu H; Babu-Khan S; Vassar R; Biere AL; Citron M; Landreth G
J Neurosci; 2003 Aug; 23(20):7504-9. PubMed ID: 12930788
[TBL] [Abstract][Full Text] [Related]
10. NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease.
Varvel NH; Bhaskar K; Kounnas MZ; Wagner SL; Yang Y; Lamb BT; Herrup K
J Clin Invest; 2009 Dec; 119(12):3692-702. PubMed ID: 19907078
[TBL] [Abstract][Full Text] [Related]
11. Non-steroidal anti-inflammatory drugs and Alzheimer's disease: the epidemiological evidence.
Szekely CA; Zandi PP
CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):132-9. PubMed ID: 20205647
[TBL] [Abstract][Full Text] [Related]
12. NSAID use and dementia risk in the Cardiovascular Health Study: role of APOE and NSAID type.
Szekely CA; Breitner JC; Fitzpatrick AL; Rea TD; Psaty BM; Kuller LH; Zandi PP
Neurology; 2008 Jan; 70(1):17-24. PubMed ID: 18003940
[TBL] [Abstract][Full Text] [Related]
13. Is it All Said for NSAIDs in Alzheimer's Disease? Role of Mitochondrial Calcium Uptake.
Sanz-Blasco S; Calvo-Rodriguez M; Caballero E; Garcia-Durillo M; Nunez L; Villalobos C
Curr Alzheimer Res; 2018; 15(6):504-510. PubMed ID: 29283047
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory treatment in AD mice protects against neuronal pathology.
Choi JK; Jenkins BG; Carreras I; Kaymakcalan S; Cormier K; Kowall NW; Dedeoglu A
Exp Neurol; 2010 Jun; 223(2):377-84. PubMed ID: 19679126
[TBL] [Abstract][Full Text] [Related]
15. No improvement after chronic ibuprofen treatment in the 5XFAD mouse model of Alzheimer's disease.
Hillmann A; Hahn S; Schilling S; Hoffmann T; Demuth HU; Bulic B; Schneider-Axmann T; Bayer TA; Weggen S; Wirths O
Neurobiol Aging; 2012 Apr; 33(4):833.e39-50. PubMed ID: 21943956
[TBL] [Abstract][Full Text] [Related]
16. Use of nonsteroidal anti-inflammatory drugs and gastroprotective agents before the advent of cyclooxygenase-2-selective inhibitors: analysis of a large United States claims database.
Schnitzer TJ; Kong SX; Mavros PP; Straus WL; Watson DJ
Clin Ther; 2001 Dec; 23(12):1984-98. PubMed ID: 11813933
[TBL] [Abstract][Full Text] [Related]
17. [Non-steroidal anti-inflammatory drugs with selectivity for cyclooxygenase-2 in Alzheimer's disease. Rationale and perspectives].
Blain H; Jouzeau JY; Blain A; Terlain B; Tréchot P; Touchon J; Netter P; Jeandel C
Presse Med; 2000 Feb; 29(5):267-73. PubMed ID: 10701410
[TBL] [Abstract][Full Text] [Related]
18. NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo.
Eriksen JL; Sagi SA; Smith TE; Weggen S; Das P; McLendon DC; Ozols VV; Jessing KW; Zavitz KH; Koo EH; Golde TE
J Clin Invest; 2003 Aug; 112(3):440-9. PubMed ID: 12897211
[TBL] [Abstract][Full Text] [Related]
19. Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action.
Gasparini L; Ongini E; Wenk G
J Neurochem; 2004 Nov; 91(3):521-36. PubMed ID: 15485484
[TBL] [Abstract][Full Text] [Related]
20. NSAIDs for the chemoprevention of Alzheimer's disease.
Szekely CA; Town T; Zandi PP
Subcell Biochem; 2007; 42():229-48. PubMed ID: 17612054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
